Validation of Systemic and Local Tumour Immune Response to Eribulin Chemotherapy in the Treatment of Breast Cancer
Shinichiro Kashiwagi(Osaka Metropolitan University), Masaichi Ohira(Osaka Metropolitan University)
Cited by 18
Related Papers
A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study
|BMC Cancer|2018|49
Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
|International Journal of Oncology|2019|31